Skip to main content

Table 3 Demographic data of the patients(N=156)

From: Combined use of intranasal Dexmedetomidine and an oral novel formulation of Midazolam for sedation of young children during brain MRI examination: a prospective, single-center, randomized controlled trial

Group

n=

Male/Female

Age (month,‾x±SD)

Weight (kg,‾x ±SD)

The duration of examination (minute, x ±SD)

A-Group

77

48/29

30.34±15.67

13.04±3.14

35.50±8.65

B-Group

79

56/23

27.68±17.51

12.72±3.68

38.50±12.45

χ2

 

1.282

   

t

  

0.997

0.585

0.645

p

 

0.257

0.109

0.111

0.350

  1. Notes: All the data were normal distribution, and expressed as the mean ± standard deviation (SD). Enumeration data are expressed as a number.